CLINICAL BIOCHEMISTRY, vol.30, no.1, pp.53-56, 1997 (SCI-Expanded)
Objectives: CA 15-3 and CEA are considered useful tumor markers in monitoring breast cancer patients. This study was undertaken to specifically evaluate the transient elevations in these markers that are observed during systemic treatment for metastatic disease. This phenomenon has been termed ''spiking.''